USPTO Patent Application for Digital Therapeutics Combination Therapy
Summary
The USPTO has published patent application US20260080800A1 for a combination therapy involving digital therapeutics and non-digital interventions, such as medicinal agents, aimed at decreasing pro-inflammatory molecules. The application was filed by REMEPY HEALTH LTD.
What changed
This document is a publication of a patent application (US20260080800A1) filed by REMEPY HEALTH LTD. The application describes a combination therapy that integrates digital therapeutics with non-digital interventions, like medicinal agents, to reduce pro-inflammatory molecules. The digital therapeutic delivery methods include sensory inhibition, substitution, or integration.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in the digital therapeutics and combination therapy space, which may impact product development and market strategies for pharmaceutical and medical device companies.
Archived snapshot
Mar 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMBINATION THERAPY WITH DIGITAL THERAPEUTICS FOR IMPROVED IMMUNE FUNCTION
Application US20260080800A1 Kind: A1 Mar 19, 2026
Assignee
REMEPY HEALTH LTD
Inventors
Amir AMEDI, Michal TSUR-SHALEV, Or SHOVAL, Shahar SHELLY, Nira Neomi SAPORTA
Abstract
The presently disclosed subject matter relates to the field of digital therapeutics to decrease pro-inflammatory molecules such as cytokines and chemokines. A primary mode of delivering the digital therapeutics is using sensory means comprising: sensory inhibition, sensory substitution, sensory integration, or a combination thereof. The invention also provides combination therapies that comprise digital interventions together with non-digital interventions such as medicinal agents.
CPC Classifications
G09B 19/00 A61B 5/4088 A61B 5/4848 A61B 5/7475 A61M 21/00 A63F 9/0612 G16B 40/00 G16H 10/20 G16H 10/60 G16H 20/10 G16H 20/17 G16H 20/30 G16H 20/70 G16H 50/30 A61M 2021/0022 A61M 2021/0027 A61M 2021/005 A63F 2300/10 A63F 2300/30 A63F 2300/8094
Filing Date
2025-11-26
Application No.
19401541
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.